Table 1 The demographic and clinical characteristics between the overall cohort and two comparison groups
Laparoscopic (N = 16) | Laparotomic (N = 21) | P—value | Overall (N = 37) | |
|---|---|---|---|---|
Age (y) | 44.5 ± 15.3/44.5 (14–73) | 48.33 ± 15.6/49.0 (16–79) | 0.460 | 46.7 ± 15.4/48.0 (14–79) |
BMI (kg/m2) | 24.6 ± 4.5/23.4 (15.6 – 35.2) | 23.8 ± 2.9/24.0 (17.7 – 29.0) | 0.524 | 24.1 ± 3.6/23.4 (15.6 – 35.2) |
Mass size (cm) | 10.5 ± 5.9/9.0 (2.3 – 25.0) | 11.3 ± 5.6/10.5 (1.9–21.5) | 0.690 | 11.0 ± 5.6/9.1 (1.9 – 25.0) |
Pre-CA125 level (mean/median, U/ml) | 782.3/39.1 (10.6 – 6735.6) | 148.7/45.6 (9.4 – 1214.9) | 0.137 | 422.7/45.6 (9.4 – 6735.6) |
FIGO stage | ||||
IA | 1 | 2 | 3 (8.1%) | |
IC | 13 | 15 | 28 (75.7%) | |
IIA | 1 | 1 | 2 (5.4%) | |
IIB | 1 | 3 | 4 (10.8%) | |
Pathology | ||||
Serous | 6 | 9 | 15 (40.5%) | |
Endometroid | 1 | 2 | 3 (8.1%) | |
Mucinous | 4 | 5 | 9 (24.3%) | |
Clear cell | 1 | 1 | 2 (5.4%) | |
MGCT | 0 | 3 | 3 (8.1%) | |
DG | - | 1 | 1 | |
YST | - | 1 | 1 | |
EC | - | 1 | 1 | |
AGCT | 3 | 1 | 4 (10.8%) | |
ESS | 1 | 0 | 1 (2.7%) | |
Follow-up time (m) | 48.4/43.5 (14—100) | 66.6/75.0 (17—117) | 0.063 | 58.7/54.0 (14 – 117) |